Samuel F. Straface
Vorstandsvorsitzender bei Medrobotics Corp.
Profil
Samuel F.
Straface was the founder of Triton BioSystems, Inc. (founded in 2001) where he held the title of President & Chief Executive Officer.
He is currently the President, Chief Executive Officer & Director at Medrobotics Corp.
since 2009 and Principal at PLSG Capital Investment Programs since 2009.
Dr. Straface has previously held positions as President & Chief Executive Officer at Aduro BioTech, Inc. from 2001 to 2006, Chief Executive Officer at Sensera, Inc. in 2004, Director-New Ventures at Boston Scientific Corp.
from 1997 to 2001, and General Manager at Johnson & Johnson from 1995 to 1997.
He also worked as a Consultant at SV Health Investors LLC in 2007 and as a Venture Partner at Pittsburgh Life Sciences Green House from 2007 to 2019.
Dr. Straface obtained a doctorate degree from The University of Western Australia in 1988.
Aktive Positionen von Samuel F. Straface
Unternehmen | Position | Beginn |
---|---|---|
PLSG Capital Investment Programs
PLSG Capital Investment Programs Investment ManagersFinance Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | - |
Medrobotics Corp.
Medrobotics Corp. Electronic Equipment/InstrumentsElectronic Technology Medrobotics Corp. operates as a surgical products company which develops flexible robot platforms. It manufactures and markets product, Flex System, a computer-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The firm's Flex System is based on a core flexible endoscope technology that surgeons can use with an integrated high-definition vision system to navigate around anatomy in a way that is not possible with line-of-sight approaches. The company was founded by Howie Choset, Marco A. Zenati and Alon Wolf in 2005 and is headquartered in Raynham, MA. | Vorstandsvorsitzender | 29.07.2009 |
Ehemalige bekannte Positionen von Samuel F. Straface
Unternehmen | Position | Ende |
---|---|---|
Pittsburgh Life Sciences Green House
Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Private Equity Investor | 01.12.2019 |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Corporate Officer/Principal | 31.12.2007 |
Triton BioSystems, Inc. | Vorstandsvorsitzender | 31.12.2006 |
CHINOOK THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.12.2006 |
Sensera, Inc.
Sensera, Inc. SemiconductorsElectronic Technology Part of Johnson & Johnson, Sensera, Inc. is a company that manufactures sensors and modules. The company is based in Woburn, MA. The company was founded by Marc-Andre Lebel. Sensera was acquired by ABIOMED, Inc., a subsidiary of Johnson & Johnson from Sensera Ltd. on January 04, 2022 for $7.50 million. | Vorstandsvorsitzender | 31.12.2004 |
Ausbildung von Samuel F. Straface
The University of Western Australia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 7 |
---|---|
PLSG Capital Investment Programs
PLSG Capital Investment Programs Investment ManagersFinance Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania. | Finance |
Medrobotics Corp.
Medrobotics Corp. Electronic Equipment/InstrumentsElectronic Technology Medrobotics Corp. operates as a surgical products company which develops flexible robot platforms. It manufactures and markets product, Flex System, a computer-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The firm's Flex System is based on a core flexible endoscope technology that surgeons can use with an integrated high-definition vision system to navigate around anatomy in a way that is not possible with line-of-sight approaches. The company was founded by Howie Choset, Marco A. Zenati and Alon Wolf in 2005 and is headquartered in Raynham, MA. | Electronic Technology |
Triton BioSystems, Inc. | Health Technology |
Pittsburgh Life Sciences Green House
Pittsburgh Life Sciences Green House Investment ManagersFinance Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
Sensera, Inc.
Sensera, Inc. SemiconductorsElectronic Technology Part of Johnson & Johnson, Sensera, Inc. is a company that manufactures sensors and modules. The company is based in Woburn, MA. The company was founded by Marc-Andre Lebel. Sensera was acquired by ABIOMED, Inc., a subsidiary of Johnson & Johnson from Sensera Ltd. on January 04, 2022 for $7.50 million. | Electronic Technology |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Finance |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |